Meg Tirrell, STAT

Meg Tirrell

STAT

New York, NY, United States

Contact Meg

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • STAT
  • CNBC
  • NBC News

Past articles by Meg:

A longtime investor talks interest rates, biotech, and why luxury cars are a warning sign

This week the central bank hiked interest rates by three quarters of a percentage point, the biggest increase since 1994. A health care portfolio manager joined the hosts of "The Readout LOUD" this week to discuss the impact it could have on biotech. → Read More

An emergency doctor and parent sorts through Covid vaccine options for kids under 5

How should parents look at the two possible Covid vaccine options for kids under 5? STAT spoke with Jeremy Faust, an emergency physician and dad who’s sorting through all of this himself. → Read More

Two years into the coronavirus pandemic, Fauci hopes the world will not forget lessons from a 'catastrophic experience'

Two years after the World Health Organization declared the coronavirus a pandemic, public health experts warn not to become complacent. → Read More

Jennifer Doudna and Marty Chavez on where CRISPR meets Wall Street

Nobel Prize-winning pioneer of CRISPR genome editing Jennifer Doudna and Sixth Street vice chairman Marty Chavez discuss where science is heading, and what business Wall Street has in CRISPR in the first place. → Read More

Biotech stocks are a dumpster fire. An analyst explains what's going on

What's ailing biotech stocks lately? An analyst offers some explanations. → Read More

Johnson & Johnson CFO Wolk on Q3 earnings, Covid vaccine booster

CNBC's Meg Tirrell and the 'Squawk Box' team sit down with Johnson & Johnson CFO Joseph Wolk to discuss the company's latest quarterly earnings, as well as its regulatory bid for a Covid-19 vaccine booster. → Read More

CDC director says when the Covid pandemic ends depends on human behavior

CDC Director Dr Rochelle Walensky says ending this pandemic comes down to human behavior, which "hasn't served us very well" so far → Read More

The next flu season will be a 'whopper,' former FDA chief Scott Gottlieb says

Former FDA Commissioner Dr. Scott Gottlieb speaks with CNBC's Meg Tirrell about the future of work as businesses reimagine the workday. Gottlieb discusses how employers can improve office safety, how flu season may become more complicated now that Covid-19 is likely here to stay, the Biden administration's vaccine mandate, vaccinating children and his new book "Uncontrolled Spread: Why Covid-19… → Read More

CNBC Exclusive: How Moderna and Pfizer-BioNTech developed vaccines in record time

Developing a vaccine in less than a year for a novel pathogen had never been done before Covid-19. Three companies did it using a completely novel technology, messenger RNA. CNBC Digital's documentary tells the behind-the-scenes story of how they did it. → Read More

A race against Covid: How Moderna and Pfizer-BioNTech developed vaccines in record time

The teams at Moderna, Pfizer and BioNTech recount the historic race to develop Covid-19 vaccines in a newly released documentary by CNBC. → Read More

Biden administration to recommend the vaccinated wear masks in areas with low vaccination rates

Administration officials had been struggling in recent days with how to respond to a rising number of Covid-19 infections and hospitalization among those who are fully vaccinated. → Read More

How concerned should we be about breakthrough coronavirus infections?

Céline Gounder speaks with STAT about the Delta variant, vaccinations, and the future of the Covid-19 pandemic. → Read More

U.S. is in discussions with Moderna on buying Covid vaccine doses for other nations

A medical worker from Parrish Medical Center holds a vial of the Moderna COVID-19 vaccine at a drive through vaccination clinic for employees of Port Canaveral, workers at local hotels and restaurants, and residents of the Port Canaveral community. Paul Hennessy | LightRocket | Getty Images The U.S. government is in negotiations with Moderna to potentially secure additional Covid-19 vaccine… → Read More

Grilling Scott Gottlieb on burgers, drugs, a post-pandemic summer

The former FDA commissioner chats about the proper temperature of a backyard burger and why the origins of Covid are important for science. → Read More

Almost 20% of unvaccinated Americans still prefer J&J Covid vaccine after U.S. pause, survey shows

The number of Americans who prefer J&J's Covid-19 vaccine declined after the U.S. paused its use to investigate safety, but 17% still say it's their top choice. → Read More

An antitrust expert weighs in on the FTC's complaint against Illumina

The FTC has said if Illumina were to acquire Grail, it would have incentive to raise prices on competitors to give Grail an unfair advantage. → Read More

What to make of AstraZeneca's vaccine data — and debate around them

AstraZeneca’s up-and-down quest to develop a vaccine for Covid-19 stands out from what has otherwise been a straightforward process. → Read More

British health journalist weighs in on U.K. vs. U.S. vaccine response

A conversation with The Economist's health policy editor, Natasha Loder, about vaccine trials in the U.S. versus the U.K. → Read More

The search for new Covid drugs — and a researcher's reason for optimism

David Fajgenbaum, whose lab is working to catalog and analyze drugs that might work against Covid-19, joined STAT's podcast recently. → Read More

Merck CEO says public service is in his future, but not politics, as he plans June retirement

Merck CEO Ken Frazier is retiring in June. He leaves a legacy of a focus on research, and a commitment to social justice that he's likely to continue. → Read More